MGX
Metagenomi Inc.

779
Mkt Cap
$61.7M
Volume
74,722.00
52W High
$3.95
52W Low
$1.23
PE Ratio
-0.70
MGX Fundamentals
Price
$1.60
Prev Close
$1.64
Open
$1.62
50D MA
$1.60
Beta
1.12
Avg. Volume
245,000.41
EPS (Annual)
-$2.36
P/B
0.39
Rev/Employee
$211,848.74
$59.80
Loading...
Loading...
News
all
press releases
Metagenomi (MGX) Projected to Post Quarterly Earnings on Monday
Metagenomi (NASDAQ:MGX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
Metagenomi Therapeutics (MGX) delivered earnings and revenue surprises of -4.35% and -54.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Metagenomi, Inc. (NASDAQ:MGX) Sees Significant Drop in Short Interest
Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 1,982,687...
MarketBeat·9d ago
News Placeholder
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
Amphastar (AMPH) delivered earnings and revenue surprises of -24.49% and -5.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five ratings firms that are currently covering the company, MarketBeat...
MarketBeat·17d ago
News Placeholder
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have received an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
Metagenomi (NASDAQ:MGX) Shares Down 1.2% - Here's Why
Metagenomi (NASDAQ:MGX) Shares Down 1.2% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are currently covering the stock, MarketBeat reports...
MarketBeat·2mo ago
News Placeholder
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1%
Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling 2,045,457 shares, an...
MarketBeat·2mo ago
News Placeholder
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Metagenomi, Inc. (NASDAQ:MGX - Get Free Report) has received a consensus rating of "Moderate Buy" from the five research firms that are covering the firm, MarketBeat Ratings reports. One research...
MarketBeat·3mo ago
<
1
2
...
>

Latest MGX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.